Search Results - "Medina, Benjamin D"
-
1
Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor
Published in Clinical cancer research (15-02-2018)“…Imatinib dramatically reduces gastrointestinal stromal tumor (GIST) F-FDG uptake, providing an early indicator of treatment response. Despite decreased glucose…”
Get full text
Journal Article -
2
Rethinking T Cells in Pancreas Cancer
Published in Clinical cancer research (01-07-2019)“…Patients with pancreatic ductal adenocarcinoma do not benefit from checkpoint blockade. However, human tumors harbor evidence of adaptive immunity in clonally…”
Get full text
Journal Article -
3
Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor
Published in The Journal of clinical investigation (01-05-2019)“…Gastrointestinal stromal tumor (GIST) is the most common human sarcoma, frequently characterized by an oncogenic mutation in the KIT or platelet-derived growth…”
Get full text
Journal Article -
4
PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors
Published in Clinical cancer research (15-01-2017)“…Tyrosine kinase inhibitors are effective in gastrointestinal stromal tumors (GISTs) but often are of transient benefit as resistance commonly develops…”
Get full text
Journal Article -
5
Just breathe: 12-step robotic tracheobronchoplasty
Published in JTCVS techniques (01-10-2023)Get full text
Journal Article -
6
Characterizing a learning curve for robotic-assisted bronchoscopy: Analysis of skills acquisition in a high-volume academic center
Published in The Journal of thoracic and cardiovascular surgery (25-06-2024)“…Shape-sensing robotic-assisted bronchoscopy is an emerging technology for the sampling of pulmonary lesions. We seek to characterize the shape-sensing…”
Get full text
Journal Article -
7
Percutaneous Dilational Tracheostomy at the Epicenter of the SARS-CoV-2 Pandemic: Impact on Critical Care Resource Utilization and Early Outcomes
Published in The American surgeon (01-11-2021)“…The COVID-19 pandemic overwhelmed New York City hospitals early in the pandemic. Shortages of ventilators and sedatives prompted tracheostomy earlier than…”
Get more information
Journal Article -
8
Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity
Published in The Journal of experimental medicine (03-06-2019)“…Gastrointestinal stromal tumor (GIST) is driven by an activating mutation in the proto-oncogene. Using a mouse model of GIST and human specimens, we show that…”
Get full text
Journal Article -
9
The V654A second-site KIT mutation increases tumor oncogenesis and STAT activation in a mouse model of gastrointestinal stromal tumor
Published in Oncogene (03-12-2020)“…Gastrointestinal stromal tumor (GIST) is the most common human sarcoma and arises in the gastrointestinal tract. Most GISTs are caused by activating mutations…”
Get full text
Journal Article -
10
Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy
Published in Journal of surgical oncology (01-09-2020)“…Background and Objectives Metastasectomy for melanoma provides durable disease control in carefully selected patients. Similarly, BRAF‐targeted and immune…”
Get full text
Journal Article -
11
Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor
Published in Molecular cancer therapeutics (01-09-2017)“…Gastrointestinal stromal tumor (GIST) is the most common type of sarcoma and usually harbors either a or mutation. However, the molecular basis for tumor…”
Get full text
Journal Article -
12
Macrophages and CD8 + T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors
Published in Cancer immunology research (01-04-2018)“…Tyrosine kinase inhibition of gastrointestinal stromal tumors (GIST) is effective but typically culminates in resistance and is rarely curative. Immunotherapy…”
Get more information
Journal Article -
13
Tyrosine Kinase Inhibition Activates Intratumoral γδ T Cells in Gastrointestinal Stromal Tumor
Published in Cancer immunology research (03-01-2024)“…γδ T cells are a rare but potent subset of T cells with pleiotropic functions. They commonly reside within tumors but the response of γδ T cells to tyrosine…”
Get more information
Journal Article -
14
Oncogenic KIT Modulates Type I IFN-Mediated Antitumor Immunity in GIST
Published in Cancer immunology research (01-05-2021)“…Type I IFNs are implicated in tumor immunogenicity and response to systemic therapy, but their interaction with oncogene signaling is not well understood…”
Get more information
Journal Article -
15
Tyrosine Kinase Inhibition Alters Intratumoral CD8+ T-cell Subtype Composition and Activity
Published in Cancer immunology research (04-10-2022)“…Targeted therapy with a tyrosine kinase inhibitor (TKI) such as imatinib is effective in treating gastrointestinal stromal tumor (GIST), but it is rarely…”
Get more information
Journal Article -
16
ETV4 collaborates with Wnt/β-catenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumor
Published in Oncotarget (26-12-2017)“…Gastrointestinal stromal tumor (GIST) is the most common sarcoma, often resulting from a or platelet-derived growth factor receptor alpha ( ) mutation. The…”
Get full text
Journal Article -
17
Metastatic Colorectal Carcinoma
Published in Surgical Decision Making (01-01-2020)Get full text
Book Chapter